The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Bacteria‐Based Cancer Immunotherapy
Open accessAbstract
In the past decade, bacteria‐based cancer immunotherapy has attracted much attention in the academic circle due to its unique mechanism and abundant applications in triggering the host anti‐tumor immunity. One advantage of bacteria lies in their capability in targeting tumors and preferentially colonizing the core area of the tumor. Because bacteria are abundant in pathogen‐associated molecular patterns that can effectively activate the immune cells even in the tumor immunosuppressive microenvironment, they are capable of enhancing the specific immune recognition and elimination of tumor cells. More attractively, during the rapid development of synthetic biology, using gene technology to enable bacteria to be an efficient producer of immunotherapeutic agents has led to many creative immunotherapy paradigms. The combination of bacteria and nanomaterials also displays infinite imagination in the multifunctional endowment for cancer immunotherapy. The current progress report summarizes the recent advances in bacteria‐based cancer immunotherapy with specific foci on the applications of naive bacteria‐, engineered bacteria‐, and bacterial components‐based cancer immunotherapy, and at the same time discusses future directions in this field of research based on the present developments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
Schwechheimer, C., & Kuehn, M. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3525 · Cited by 1,922
Regulatory T cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2017) · Cell Research · doi:10.1038/cr.2016.151 · Cited by 1,860
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
Kulp, A., & Kuehn, M. J. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.091208.073413 · Cited by 1,533
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf
Miao, E. A., Alpuche-Aranda, C. M., Dors, M., Clark, A. E., Bader, M. W., Miller, S. I., & Aderem, A. (2006) · Nature Immunology · doi:10.1038/ni1344 · Cited by 1,127
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Beatty, G. L., & Gladney, W. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1860 · Cited by 1,078
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Ohue, Y., & Nishikawa, H. (2019) · Cancer Science · doi:10.1111/cas.14069 · Cited by 1,041
Immune modulation by bacterial outer membrane vesicles
Kaparakis-Liaskos, M., & Ferrero, R. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3837 · Cited by 1,019
Ahn, D.-G., Shin, H.-J., Kim, M.-H., Lee, S., Kim, H.-S., Myoung, J., Kim, B.-T., & Kim, S.-J. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2003.03011 · Cited by 1,001
Dannull, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25947 · Cited by 989
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905
Chen, Z., Zhao, P., Luo, Z., Zheng, M., Tian, H., Gong, P., Gao, G., Pan, H., Liu, L., Ma, A., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b04695 · Cited by 895
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Self-citationSynchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster
Triantafilou, M., & Triantafilou, K. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02233-0 · Cited by 730
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Chowdhury, S., Castro, S., Coker, C., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2019) · Nature Medicine · doi:10.1038/s41591-019-0498-z · Cited by 724
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Fu, J., Kanne, D. B., Leong, M., Glickman, L. H., McWhirter, S. M., Lemmens, E., Mechette, K., Leong, J. J., Lauer, P., Liu, W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4306 · Cited by 720
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 715
Shae, D., Becker, K. W., Christov, P., Yun, D. S., Lytton-Jean, A. K. R., Sevimli, S., Ascano, M., Kelley, M., Johnson, D. B., Balko, J. M., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0342-5 · Cited by 668
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Gurbatri, C. R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P. M., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0876 · Cited by 647
Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update
Jan, A. T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01053 · Cited by 617
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Kim, O. Y., Park, H. T., Dinh, N. T. H., Choi, S. J., Lee, J., Kim, J. H., Lee, S.-W., & Gho, Y. S. (2017) · Nature Communications · doi:10.1038/s41467-017-00729-8 · Cited by 616
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Hatfield, S. M., Kjaergaard, J., Lukashev, D., Schreiber, T. H., Belikoff, B., Abbott, R., Sethumadhavan, S., Philbrook, P., Ko, K., Cannici, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1260 · Cited by 600
Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aak9537 · Cited by 588
Combination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Gujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria
Roier, S., Zingl, F. G., Cakar, F., Durakovic, S., Kohl, P., Eichmann, T. O., Klug, L., Gadermaier, B., Weinzerl, K., Prassl, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms10515 · Cited by 498
Microbiome and Anticancer Immunosurveillance
Zitvogel, L., Ayyoub, M., Routy, B., & Kroemer, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.001 · Cited by 478
Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production
Brynildsen, M. P., Winkler, J. A., Spina, C. S., MacDonald, I. C., & Collins, J. J. (2013) · Nature Biotechnology · doi:10.1038/nbt.2458 · Cited by 470
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Leventhal, D. S., Sokolovska, A., Li, N., Plescia, C., Kolodziej, S. A., Gallant, C. W., Christmas, R., Gao, J.-R., James, M. J., Abin-Fuentes, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16602-0 · Cited by 458
Abdel-Wahab, N., Shah, M., & Suarez-Almazor, M. E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160221 · Cited by 444
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 410
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
Shi, Y., Zheng, W., Yang, K., Harris, K. G., Ni, K., Xue, L., Lin, W., Chang, E. B., Weichselbaum, R. R., & Fu, Y.-X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192282 · Cited by 409
(2013) · Seminars in Immunopathology · doi:10.1007/281.1863-2300 · Cited by 392
Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy
Chen, W., Wang, Y., Qin, M., Zhang, X., Zhang, Z., Sun, X., & Gu, Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b02235 · Cited by 380
Self-citationCutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
Larkin, B., Ilyukha, V., Sorokin, M., Buzdin, A., Vannier, E., & Poltorak, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601999 · Cited by 361
Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J., Bermudes, D., Brecher, S. M., Margitich, D., Turnier, J., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315497 · Cited by 355
Chalifour, A., Jeannin, P., Gauchat, J.-F., Blaecke, A., Malissard, M., N'Guyen, T., Thieblemont, N., & Delneste, Y. (2004) · Blood · doi:10.1182/blood-2003-08-2820 · Cited by 351
Bacteria in cancer therapy: a novel experimental strategy
Patyar, S., Joshi, R., Byrav, D. P., Prakash, A., Medhi, B., & Das, B. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-21 · Cited by 340
Proteomics in gram‐negative bacterial outer membrane vesicles
Lee, E., Choi, D., Kim, K., & Gho, Y. S. (2008) · Mass Spectrometry Reviews · doi:10.1002/mas.20175 · Cited by 339
Optically-controlled bacterial metabolite for cancer therapy
Zheng, D.-W., Chen, Y., Li, Z.-H., Xu, L., Li, C.-X., Li, B., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03233-9 · Cited by 324
Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
Thakkar, S., Sharma, D., Kalia, K., & Tekade, R. K. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.009 · Cited by 316
A review of the development of tumor vasculature and its effects on the tumor microenvironment
Forster, J., Harriss-Phillips, W., Douglass, M., & Bezak, E. (2017) · Hypoxia · doi:10.2147/hp.s133231 · Cited by 313
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Sedighi, M., Zahedi Bialvaei, A., Hamblin, M. R., Ohadi, E., Asadi, A., Halajzadeh, M., Lohrasbi, V., Mohammadzadeh, N., Amiriani, T., Krutova, M., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2148 · Cited by 308
Bacteriolytic therapy can generate a potent immune response against experimental tumors
Agrawal, N., Bettegowda, C., Cheong, I., Geschwind, J.-F., Drake, C. G., Hipkiss, E. L., Tatsumi, M., Dang, L. H., Diaz, L. A., Pomper, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406242101 · Cited by 304
Self-citationChen, Q., Bai, H., Wu, W., Huang, G., Li, Y., Wu, M., Tang, G., & Ping, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b02182 · Cited by 304
Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy
Li, M., Li, S., Zhou, H., Tang, X., Wu, Y., Jiang, W., Tian, Z., Zhou, X., Yang, X., & Wang, Y. (2020) · Nature Communications · doi:10.1038/s41467-020-14963-0 · Cited by 300
Self-citationTLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system
Miao, E. A., Andersen-Nissen, E., Warren, S. E., & Aderem, A. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0078-z · Cited by 297
Nauts, H. C., Swift, W. E., & Coley, B. L. (1946) · PubMed · Cited by 290
Engineering Nanoparticle-Coated Bacteria as Oral DNA Vaccines for Cancer Immunotherapy
Hu, Q., Wu, M., Fang, C., Cheng, C., Zhao, M., Fang, W., Chu, P. K., Ping, Y., & Tang, G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b00570 · Cited by 286
Bacteria and cancer: cause, coincidence or cure? A review
Mager, D. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-14 · Cited by 278
Malmgren, R. A., & Flanigan, C. (1955) · PubMed · Cited by 263
Samavati, L., Rastogi, R., Du, W., Hüttemann, M., Fite, A., & Franchi, L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.018 · Cited by 256
Kasinskas, R. W., & Forbes, N. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2618 · Cited by 250
Nanotechnology intervention of the microbiome for cancer therapy
Song, W., Anselmo, A. C., & Huang, L. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0589-5 · Cited by 246
Mahnke, K., Schönfeld, K., Fondel, S., Ring, S., Karakhanova, S., Wiedemeyer, K., Bedke, T., Johnson, T. S., Storn, V., Schallenberg, S., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22617 · Cited by 244
Leschner, S., Westphal, K., Dietrich, N., Viegas, N., Jablonska, J., Lyszkiewicz, M., Lienenklaus, S., Falk, W., Gekara, N., Loessner, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006692 · Cited by 236
Chen, Q., Huang, G., Wu, W., Wang, J., Hu, J., Mao, J., Chu, P. K., Bai, H., & Tang, G. (2020) · Advanced Materials · doi:10.1002/adma.201908185 · Cited by 236
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
Wang, H., Franco, F., & Ho, P.-C. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.06.005 · Cited by 234
Patel, R. B., Ye, M., Carlson, P. M., Jaquish, A., Zangl, L., Ma, B., Wang, Y., Arthur, I., Xie, R., Brown, R. J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201902626 · Cited by 231
Self-citationStritzker, J., Weibel, S., Hill, P. J., Oelschlaeger, T. A., Goebel, W., & Szalay, A. A. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.01.008 · Cited by 224
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
Wilson, D. R., Sen, R., Sunshine, J. C., Pardoll, D. M., Green, J. J., & Kim, Y. J. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.10.013 · Cited by 220
Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity
Saccheri, F., Pozzi, C., Avogadri, F., Barozzi, S., Faretta, M., Fusi, P., & Rescigno, M. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000739 · Cited by 218
Xu, F., Huang, X., Wang, Y., & Zhou, S. (2020) · Advanced Materials · doi:10.1002/adma.201906745 · Cited by 217
Self-citationKim, S. H., Castro, F., Paterson, Y., & Gravekamp, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4855 · Cited by 210
Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro
Kasinskas, R. W., & Forbes, N. S. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20883 · Cited by 209
Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria
Kulkarni, H. M., & Jagannadham, M. V. (2014) · Microbiology · doi:10.1099/mic.0.079400-0 · Cited by 206
Modulation of bacterial outer membrane vesicle production by envelope structure and content
Schwechheimer, C., Kulp, A., & Kuehn, M. J. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0324-1 · Cited by 200
Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β
Kim, J.-E., Phan, T. X., Nguyen, V. H., Dinh-Vu, H.-V., Zheng, J. H., Yun, M., Park, S.-G., Hong, Y., Choy, H. E., Szardenings, M., et al. (2015) · Theranostics · doi:10.7150/thno.11432 · Cited by 200
The Bacterial Flagellum and Flagellar Motor: Structure, Assembly and Function
Jones, C. J., & Aizawa, S.-I. (1991) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60007-7 · Cited by 196
Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer
Sfondrini, L., Rossini, A., Besusso, D., Merlo, A., Tagliabue, E., Mènard, S., & Balsari, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6624 · Cited by 194
Song, W., Tiruthani, K., Wang, Y., Shen, L., Hu, M., Dorosheva, O., Qiu, K., Kinghorn, K. A., Liu, R., & Huang, L. (2018) · Advanced Materials · doi:10.1002/adma.201805007 · Cited by 194
Self-citationLiu, L., He, H., Luo, Z., Zhou, H., Liang, R., Pan, H., Ma, Y., & Cai, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910176 · Cited by 186
Forbes, N. S., Munn, L. L., Fukumura, D., & Jain, R. K. (2003) · PubMed · Cited by 183
Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth
Loeffler, M., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701959104 · Cited by 180
Liu, X., Yin, S., Chen, Y., Wu, Y., Zheng, W., Dong, H., Bai, Y., Qin, Y., Li, J., Feng, S., et al. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8542 · Cited by 179
Visualization and In Situ Ablation of Intracellular Bacterial Pathogens through Metabolic Labeling
Hu, F., Qi, G., Kenry, Mao, D., Zhou, S., Wu, M., Wu, W., & Liu, B. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201910187 · Cited by 174
Self-citationOvercoming the hypoxic barrier to radiation therapy with anaerobic bacteria
Bettegowda, C., Dang, L. H., Abrams, R., Huso, D. L., Dillehay, L., Cheong, I., Agrawal, N., Borzillary, S., McCaffery, J. M., Watson, E. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036598100 · Cited by 172
Self-citationMultifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy
Guo, X., Wei, X., Chen, Z., Zhang, X., Yang, G., & Zhou, S. (2020) · Progress in Materials Science · doi:10.1016/j.pmatsci.2019.100599 · Cited by 171
Self-citationFenton Reaction-Assisted Photodynamic Therapy for Cancer with Multifunctional Magnetic Nanoparticles
Hou, H., Huang, X., Wei, G., Xu, F., Wang, Y., & Zhou, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b09671 · Cited by 169
Self-citationA Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs
Cheong, I., Huang, X., Bettegowda, C., Diaz, L. A., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2006) · Science · doi:10.1126/science.1130651 · Cited by 168
Self-citationAdvances in microbial physiology
(1992) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(92)90655-a · Cited by 168
The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT
Bettegowda, C., Huang, X., Lin, J., Cheong, I., Kohli, M., Szabo, S. A., Zhang, X., Diaz, L. A., Velculescu, V. E., Parmigiani, G., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1256 · Cited by 162
Self-citationWang, T., Zheng, N., Luo, Q., Jiang, L., He, B., Yuan, X., & Shen, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01235 · Cited by 148
Chandra, D., Jahangir, A., Quispe‐Tintaya, W., Einstein, M. H., & Gravekamp, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.206 · Cited by 146
Bacterial toxins and cancer — a case to answer?
Lax, A. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1130 · Cited by 145
An innovative biologic system for photon-powered myocardium in the ischemic heart
Cohen, J. E., Goldstone, A. B., Paulsen, M. J., Shudo, Y., Steele, A. N., Edwards, B. B., Patel, J. B., MacArthur, J. W., Hopkins, M. S., Burnett, C. E., et al. (2017) · Science Advances · doi:10.1126/sciadv.1603078 · Cited by 141
IL-18-producing Salmonella inhibit tumor growth
Loeffler, M. W., Le'Negrate, G., Krajewska, M., & Reed, J. C. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.48 · Cited by 135
Schwechheimer, C., Rodriguez, D. L., & Kuehn, M. J. (2015) · MicrobiologyOpen · doi:10.1002/mbo3.244 · Cited by 129
The Tumor-Immune Microenvironment and Response to Radiation Therapy
Shiao, S. L., & Coussens, L. M. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9194-9 · Cited by 127
Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium
Guo, Y., Chen, Y., Liu, X., Min, J.-J., Tan, W., & Zheng, J. H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.10.033 · Cited by 124
Kähler, K. C., Hassel, J. C., Heinzerling, L., Loquai, C., Mößner, R., Ugurel, S., Zimmer, L., & Gutzmer, R. (2016) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13047 · Cited by 121
Chen, W., Guo, Z., Zhu, Y., Qiao, N., Zhang, Z., & Sun, X. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201906623 · Cited by 119
Activation of inflammasome by attenuated Salmonella typhimurium in bacteria‐mediated cancer therapy
Phan, T. X., Nguyen, V. H., Duong, M. T.-Q., Hong, Y., Choy, H. E., & Min, J. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12333 · Cited by 116
TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases
Yang, B.-H., Wang, K., Wan, S., Liang, Y., Yuan, X., Dong, Y. W., Cho, S., Xu, W., Jepsen, K., Feng, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.061 · Cited by 115
Microbiota—myeloid cell crosstalk beyond the gut
Gorjifard, S., & Goldszmid, R. S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0516-222r · Cited by 102
Xu, F., Li, X., Huang, X., Pan, J., Wang, Y., & Zhou, S. (2020) · Science Advances · doi:10.1126/sciadv.abb8725 · Cited by 100
Self-citationSHINNOH, M., Horinaka, M., Yasuda, T., Yoshikawa, S., Morita, M., Yamada, T., Miki, T., & Sakai, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1790 · Cited by 95
Surfacing role of probiotics in cancer prophylaxis and therapy: A systematic review
Dasari, S., Kathera, C., Janardhan, A., Kumar, A. P., & Viswanath, B. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.017 · Cited by 93
Live-attenuated bacteria as a cancer vaccine vector
Toussaint, B., Chauchet, X., Wang, Y., Polack, B., & Gouëllec, A. L. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.836914 · Cited by 91
Self-citationTargeting solid tumors with non‐pathogenic obligate anaerobic bacteria
Taniguchi, S., Fujimori, M., Sasaki, T., Tsutsui, H., Shimatani, Y., Seki, K., & Amano, J. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01628.x · Cited by 89
How to improve the immunogenicity of chemotherapy and radiotherapy
Ma, Y., Conforti, R., Aymeric, L., Locher, C., Kepp, O., Kroemer, G., & Zitvogel, L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9283-2 · Cited by 88
Flagellin: key target of mucosal innate immunity
Vijay–Kumar, M., & Gewirtz, A. T. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.9 · Cited by 87
CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients
Buzzi, S., Rubboli, D., Buzzi, G., Buzzi, A. M., Morisi, C., & Pironi, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0546-4 · Cited by 85
Hypoxia-tropic Protein Nanocages for Modulation of Tumor- and Chemotherapy-Associated Hypoxia
Huang, X., Zhuang, J., Chung, S. W., Huang, B., Halpert, G., Negrón, K., Sun, X., Yang, J., Oh, Y., Hwang, P. M., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b05399 · Cited by 84
Self-citationCancer Immunoediting: From Immune Surveillance to Immune Escape
Kim, R. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50066-3 · Cited by 84
Heap, J. T., Theys, J., Ehsaan, M., Kubiak, A. M., Dubois, L. J., Paesmans, K., Mellaert, L. V., Knox, R. J., Kuehne, S. A., Lambin, P., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1761 · Cited by 81
Wu, M., Mei, T., Lin, C., Wang, Y., Chen, J., Le, W., Sun, M., Xu, J., Dai, H., Zhang, Y., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b23177 · Cited by 81
Self-citationEngineering bacteria toward tumor targeting for cancer treatment: current state and perspectives
Lee, C. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3695-3 · Cited by 79
Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy
Pahle, J., Menzel, L., Niesler, N., Kobelt, D., Aumann, J., Rivera, M., & Walther, W. (2017) · BMC Cancer · doi:10.1186/s12885-017-3123-x · Cited by 75
The role of bacterial toxins and spores in cancer therapy
Weerakkody, L. R., & Witharana, C. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116839 · Cited by 75
Cheung, L. S., Fu, J. L., Kumar, P., Kumar, A., Urbanowski, M. E., Ihms, E. A., Parveen, S., Bullen, C. K., Patrick, G. J., Harrison, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815087116 · Cited by 72
Felgner, S., Kocijancic, D., Frahm, M., Heise, U., Rohde, M., Zimmermann, K., Falk, C. S., Erhardt, M., & Weiß, S. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1382791 · Cited by 67
Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation
Chang, W., Lai, C., Chen, M., Liu, C., Kuan, Y.-D., Lin, S., & Lee, C. (2013) · International Journal of Cancer · doi:10.1002/ijc.28155 · Cited by 66
Engineering of bacterial strains and their products for cancer therapy
Bernardes, N., Chakrabarty, A. M., & Fialho, A. M. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4926-6 · Cited by 66
Huang, X., Xu, F., Hou, H., Hou, J., Wang, Y., & Zhou, S. (2019) · Nano Research · doi:10.1007/s12274-019-2307-x · Cited by 65
Self-citationBauss, F., Lechmann, M., Krippendorff, B., Staack, R. F., Herting, F., Festag, M., Imhof-Jung, S., Hesse, F., Pompiati, M., Kollmorgen, G., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.07.003 · Cited by 58
Xu, J., Saklatvala, R., Mittal, S., Deshmukh, S., & Procopio, A. T. (2020) · Advanced Science · doi:10.1002/advs.201903394 · Cited by 57
Bacterial vectors for imaging and cancer gene therapy: a review
Cronin, M. A., Stanton, R. M., Francis, K. P., & Tangney, M. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.59 · Cited by 56
Nanomaterials/microorganism-integrated microbiotic nanomedicine
Huo, M., Wang, L., Chen, Y., & Shi, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100854 · Cited by 56
Vijay–Kumar, M., Aitken, J. D., Kumar, A., Neish, A. S., Uematsu, S., Akira, S., & Gewirtz, A. T. (2008) · Infection and Immunity · doi:10.1128/iai.01491-07 · Cited by 55
The Role of FOXP3 in Regulating Immune Responses
Vent‐Schmidt, J., Han, J. M., MacDonald, K. G., & Levings, M. K. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.811657 · Cited by 46
Kupz, A., Curtiss, R., Bedoui, S., & Strugnell, R. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097418 · Cited by 44
Kassayová, M., Bobrov, N., Strojný, L., et al. (2016) · PubMed · Cited by 44
Yu, X., Guo, C., Yi, H., Qian, J., Fisher, P. B., Subjeck, J. R., & Wang, X. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1740 · Cited by 43
The Bacterial Spore: From Molecules to Systems
by, B. R. (2017) · Applied Biosafety · Cited by 43
Chen, H., Adam, A., Cheng, Y., Tang, S., Hartung, J., & Bao, E. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2986 · Cited by 39
TLR5 Ligand–Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity
Geng, D., Kaczanowska, S., Tsai, A., Younger, K., Ochoa, A. C., Rapoport, A. P., Ostrand-Rosenberg, S., & Dávila, E. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2467 · Cited by 36
Zhou, S., Zhao, Z., Lin, Y., Gong, S., Li, F., Pan, J., Li, X., Gao, Z., & Zhao, A. Z. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1177683 · Cited by 36
Self-citationUchugonova, A., Zhang, Y., Salz, R., Liu, F., Suetsugu, A., Zhang, L., Koenig, K., Hoffman, R. M., & Zhao, M. D. (2015) · PubMed · Cited by 36
Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours
Alizadeh, S., Esmaeili, A., Barzegari, A., Rafi, M. A., & Omidi, Y. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1737087 · Cited by 34
Delannoy, S., Beutin, L., Mariani‐Kurkdjian, P., Fleiss, A., Bonacorsi, S., & Fach, P. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00030 · Cited by 32
Kähler, K. C., Hassel, J. C., Heinzerling, L., Loquai, C., Thoms, K., Ugurel, S., Zimmer, L., Gutzmer, R., & (ADO), F. D. K. „. N. D. A. D. O. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14128_g · Cited by 27
Immune response to C. novyi-NT immunotherapy
DeClue, A. E., Axiak‐Bechtel, S. M., Zhang, Y., Saha, S., Zhang, L., Tung, D., & Bryan, J. N. (2018) · Veterinary Research · doi:10.1186/s13567-018-0531-0 · Cited by 23
Mazor, R., Kaplan, G., Park, D., Jang, Y., Lee, F., Kreitman, R. J., & Pastan, I. H. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.01.003 · Cited by 22
West, C., & Slevin, F. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.06.008 · Cited by 20
Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy
Kumar, P., Kumar, A., Parveen, S., Murphy, J. R., & Bishai, W. R. (2019) · Immunotherapy · doi:10.2217/imt-2019-0060 · Cited by 19
Fan, J., Cai, H., Li, Q., Du, Z., & Tan, W. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.01.017 · Cited by 13
Cited by
Wei, B., Pan, J., Yuan, R., Shao, B., Wang, Y., Guo, X., & Zhou, S. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00209 · Cited by 265
Self-citationThe Development of Live Microorganism-Based Oxygen Shuttles for Enhanced Hypoxic Tumor Therapy
Han, D., Zhang, X., Ma, Y., Yang, X., & Li, Z. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100517 · Cited by 25
Ye, L., Zhao, G., Ma, J., Gan, Q., Luo, N., Pan, D., Chen, C., Chen, X., & Ning, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02769-3 · Cited by 10
Metadata
- Authors
- Huang, X., Pan, J., Xu, F., Shao, B., Wang, Y., Guo, X., & Zhou, S.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2021-02-10
- Volume
- 8
- Issue
- 7
- Pages
- 2003572-2003572
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W3127650252
- Cited by
- 304
- References
- 155
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.